Defective osteogenic differentiation in the development of osteosarcoma. - Test2 - elhamkhani - TriplyDB

Defective osteogenic differentiation in the development of osteosarcoma.

Defective osteogenic differentiation in the development of osteosarcoma.

http://www.wikidata.org/entity/Q34700590

about

Separate and combined effects of DNMT and HDAC inhibitors in treating human multi-drug resistant osteosarcoma HosDXR150 cell line LIM mineralization protein-1 inhibits the malignant phenotypes of human osteosarcoma cells.Notch activation as a driver of osteogenic sarcoma.Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban.The Current and Future Therapies for Human Osteosarcoma.Epigenetic Mechanisms Regulating Mesenchymal Stem Cell Differentiation.The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells Enoxaparin and rivaroxaban have different effects on human mesenchymal stromal cells in the early stages of bone healing The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma CXCL12/CXCR4 signal axis plays an important role in mediating bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells.Ameloblastin induces tumor suppressive phenotype and enhances chemosensitivity to doxorubicin via Src-Stat3 inactivation in osteosarcoma.Perspectives on cancer stem cells in osteosarcoma Bone morphogenetic proteins in craniofacial surgery: current techniques, clinical experiences, and the future of personalized stem cell therapy.Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media From Human Osteosarcoma Cell Lines Reveals Secretion of Proteins Related to Tumor Progression.ICRP Publication 131: Stem Cell Biology with Respect to Carcinogenesis Aspects of Radiological Protection.CANCER STEM CELLS IN OSTEOSARCOMA The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines.Distal-less homeobox 5 is a master regulator of the osteogenesis of human mesenchymal stem cells.The regulatory landscape of osteogenic differentiation.Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.Biology of Bone Sarcomas and New Therapeutic Developments.

P2860

Q28538117-73B7619A-CFEE-4E11-97E8-3B0047976C77 Q33580856-6506C239-D9EF-4E52-A499-C74F71C355C4 Q34157487-E9949EA0-F48C-4757-9CC0-D0AFBB3CE5CF Q35940008-5339C009-91B8-4797-82F3-B6DFCCD5659E Q36514299-B7E3E423-8C61-49FF-8FB7-DD46005DB02C Q36613056-E6C24314-F6B5-4725-9893-7B7D186F3C70 Q36672392-540C19BE-2A07-42A3-9CB5-EC091F73DFA3 Q36702019-236F1731-D88C-4A58-9E6D-554A76D6081E Q36857020-2867293F-C2C0-4FC2-B5FE-302534DFB158 Q37067646-A770B33C-2684-44FE-945E-E4A0F50931AC Q37083884-A64296F4-B6B4-46A1-A19C-C097E7C54398 Q37558736-90C54F40-6A46-4643-B9EE-A1E9ABB75A87 Q38015689-B0926222-25DA-491C-9AB5-71C706487B42 Q38066205-CF1B5CA7-91E9-4C26-981C-7AADC0749640 Q38445377-3A29602D-5F31-4181-A5BE-E6C97A600336 Q38659248-8F53E095-CCF0-4A80-A8D1-861565C71202 Q38683858-F8602CF1-3572-4A08-90C6-B3661C6608C5 Q39036272-3825F229-F3CB-456C-B1E3-FF6A9C766DB9 Q42047116-07B01A52-F4F4-4262-953C-0366CED9D587 Q43660854-82E09FF4-8771-49AB-BF16-72C9749804CB Q47330690-75AB40B8-B69D-45D5-AE18-DF5DF7616E44 Q48120956-7C6757E0-95A3-4EEA-B666-FC8091568963

P2860

Defective osteogenic differentiation in the development of osteosarcoma.

http://www.wikidata.org/entity/Q34700590

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Defective osteogenic differentiation in the development of osteosarcoma.

@ast

Defective osteogenic differentiation in the development of osteosarcoma.

@en

Defective osteogenic differentiation in the development of osteosarcoma.

@nl

type

label

Defective osteogenic differentiation in the development of osteosarcoma.

@ast

Defective osteogenic differentiation in the development of osteosarcoma.

@en

Defective osteogenic differentiation in the development of osteosarcoma.

@nl

prefLabel

Defective osteogenic differentiation in the development of osteosarcoma.

@ast

Defective osteogenic differentiation in the development of osteosarcoma.

@en

Defective osteogenic differentiation in the development of osteosarcoma.

@nl

P1433

Q34700590-57716444-AA99-491B-9E43-2E5F93562498

P1476

Q34700590-4B62EC5B-40B1-4A57-82CC-874E2CE1C03B

P2093

Q34700590-0A734825-17E6-4160-9980-C5A01E6A2173

Q34700590-0E7E52AA-DB37-4986-85C7-176DB4D72C85

Q34700590-1056BDE1-DC0E-4BC8-987A-C889D1A3BC7D

Q34700590-2911F1E1-AF95-4014-A430-B0A9A0577CD5

Q34700590-2B126D69-ABCF-4BAF-904D-F19FDA32FBEE

Q34700590-3126DB35-4A62-4752-AB7E-AB8F43E408A9

Q34700590-379FE095-BBF0-41C1-AE59-39D92A679FAC

Q34700590-41E46512-C642-462F-BC02-119F93FAC3B3

Q34700590-4E5B05A4-246B-4F85-B062-AD43DF7CA9C4

Q34700590-4F181277-C5EC-442D-AEF3-F6EFDCA175E8

P2860

Q34700590-018A52C8-306A-4963-BBB0-D966F5B39851

Q34700590-025ABD5B-8C8F-4B96-90E9-367DC81F3B4C

Q34700590-0355B411-6808-42F6-9149-265F32E7F925

Q34700590-03A622B6-2A11-470A-BC0A-623F5493F7B7

Q34700590-050B6664-4C86-4513-875D-16D44C1B8909

Q34700590-069F4B0D-BDBE-4CCD-8C92-E9597C2C4B95

Q34700590-09D5E58C-8337-4DD6-8451-2C72340D1DB9

Q34700590-0A68B2FB-3ABD-498F-B975-2B40B84E3078

Q34700590-0B81D9AA-3512-466E-839A-0B6213D21B46

Q34700590-1197870C-862B-4C1D-B043-F3B2758C84BE

P304

Q34700590-2CAD2514-E05E-49D9-A7BE-143567CF796A

P31

Q34700590-756192F6-35ED-45D4-98F0-66ED794FDE2A

P356

Q34700590-0F336EA3-7F36-43A6-BF25-1879D74FF17D

P478

Q34700590-96EAFD32-1C6B-43DD-9F55-5F11962331D3

P577

Q34700590-A6738E22-6F4E-41F1-9D65-5DF5897F4037

P5875

Q34700590-EFD59741-2DEB-4370-BAAC-0E5C968730E1

P698

Q34700590-8D2C79CF-05E7-4F63-951C-7480BC2D7860

P932

Q34700590-6196A636-BF84-4C36-95A9-25B8563194C4

P356

P1433

P1476

Defective osteogenic differentiation in the development of osteosarcoma.

@en

P2093

Bai-Cheng He

http://www.w3.org/2001/XMLSchema#string

Chad Teven

http://www.w3.org/2001/XMLSchema#string

Enyi Huang

http://www.w3.org/2001/XMLSchema#string

Eric R Wagner

http://www.w3.org/2001/XMLSchema#string

Gaohui Zhu

http://www.w3.org/2001/XMLSchema#string

Gaurav Luther

http://www.w3.org/2001/XMLSchema#string

Guowei Zuo

http://www.w3.org/2001/XMLSchema#string

Hue H Luu

http://www.w3.org/2001/XMLSchema#string

Jian-Li Gao

http://www.w3.org/2001/XMLSchema#string

Jinyong Luo

http://www.w3.org/2001/XMLSchema#string

P2860

TGF-beta signal transduction

The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells

Novel regulators of bone formation: molecular clones and activities

CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells

Wnt/beta-catenin signaling in development and disease

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

Stem cells, cancer, and cancer stem cells

p53, the cellular gatekeeper for growth and division

The Wnt signaling pathway in development and disease

Controlling TGF-beta signaling

P304

325238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/325238

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50851554

http://www.w3.org/2001/XMLSchema#string

P698

21437219

http://www.w3.org/2001/XMLSchema#string

P932

3061279

http://www.w3.org/2001/XMLSchema#string